Low-Frequency, Sustained CD4 T-Cell Responses Chlamydia trachomatis in Women: Predominant Targeting of Chlamydial Proteaselike Activity Factor (CPAF)
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiae443 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Yanli Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Chlamydia trachomatis, Chlamydia Infections, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, UNC Chlamydia Vaccine Initiative.
Abstract (Originalsprache)
Background
Chlamydia trachomatis (CT) is a globally prevalent sexually transmitted infection that can result in pelvic inflammatory disease, ectopic pregnancy, and infertility in women. Currently, there is no prophylactic vaccine.
Methods
This study examined T-cell immunity in a cohort of women recently infected with CT. Participants were screened against peptides spanning 33 of 894 possible CT proteins, either ex vivo or using short-term cell lines. CT-specific T cells were characterized by interferon (IFN) γ enzyme-linked immunospot (ELISPOT) assay and flow cytometry.
Results
Ex vivo CT-specific T cells were rarely detected; however, in vitro expanded CT-specific T cells were detected by IFN-γ ELISPOT in 90% (27 of 30) of participants. Notably, >50% of participants had T-cell responses targeting chlamydial proteaselike activity factor (CPAF). T-cell epitopes were dispersed across the CPAF protein. Flow cytometric analysis of short-term cell lines found that CT-specific cells, mainly CD4, produced IFN-γ and tumor necrosis factor (TNF) α and were sustained over 12 months. Ex vivo analysis suggested that CT-specific T cells mostly exhibited a central memory phenotype.
Conclusions
Our results indicate that CT infection elicits low-frequency, persistent CD4 T-cell responses in most women and that the secreted protein, CPAF, is an immunoprevalent CT antigen. Altogether, these data support development and testing of CT vaccines that enhance CD4 T cells against CPAF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Obstetrics, Gynecology and Reproductive Sciences, The University of Pittsburgh School of Medicine, Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Genevieve Clutton, Xiaojing Zheng
Förderung
- NIAID NIH HHS
- UNC Chlamydia Vaccine Initiative
Zitieren
APA
Li, Y., Warren, J. A., Poston, T. B., Clutton, G., Shaw, F. R., Conrad, S. Z., Xu, Y., Zheng, X., Yount, K. S., O'Connell, C. M., Wiesenfeld, H. C., Darville, T., & Goonetilleke, N. (2025). Low-Frequency, Sustained CD4 T-Cell Responses Chlamydia trachomatis in Women: Predominant Targeting of Chlamydial Proteaselike Activity Factor (CPAF). The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae443
Vancouver
Li Y, Warren JA, Poston TB, Clutton G, Shaw FR, Conrad SZ, et al. Low-Frequency, Sustained CD4 T-Cell Responses Chlamydia trachomatis in Women: Predominant Targeting of Chlamydial Proteaselike Activity Factor (CPAF). The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae443
BibTeX
@article{Li2025,
author = {Li, Yanli and Warren, Joanna A and Poston, Taylor B and Clutton, Genevieve and Shaw, Fiona R and Conrad, Shayla Z and Xu, Yinyan and Zheng, Xiaojing and Yount, Kacy S and O'Connell, Catherine M and Wiesenfeld, Harold C and Darville, Toni and Goonetilleke, Nilu},
title = {Low-Frequency, Sustained CD4 T-Cell Responses Chlamydia trachomatis in Women: Predominant Targeting of Chlamydial Proteaselike Activity Factor (CPAF)},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiae443}
}
EUVIMED